MtoZ Biolabs offers De Novo protein sequencing service utilizing the state-of-the-art Orbitrap Fusion Lumos mass spectrometer, combined with our expertise in bioinformatics analysis and reverse sequence confirmation to ensure high-quality sequence analysis. Our De Novo protein sequencing service is also well-suited for analyzing multiple kinds of antibodies, including IgM and IgG antibody subtypes, and antibodies modified with FITC, biotin, and Alexa, etc., for a wide range of applications:
1. Sequence Analysis of Protein/Peptide, of which Databases are Unavailable
2. PTMs Analysis of Protein/Peptide, of which Databases are Unavailable
3. Sequence Analysis of CDR Region or Full-Length of Antibodies
Advantages of De Novo Sequencing Technology
1. No Dependence on Reference Sequences
2. High Sensitivity and Precision
3. Comprehensive Analysis of Post-Translational Modifications (PTMs)
4. Broad Applicability
